T-ACEGEL Trademark

Trademark Overview

On Friday, July 9, 2021, a trademark application was filed for T-ACEGEL with the United States Patent and Trademark Office. The USPTO has given the T-ACEGEL trademark a serial number of 90819587. The federal status of this trademark filing is REGISTERED as of Tuesday, February 13, 2024. This trademark is owned by T-ACE Medical Co., Ltd.. The T-ACEGEL trademark is filed in the Pharmaceutical Products category with the following description:

Diagnostic reagents and contrast media for medical use; Medicines for human purposes, namely, medicines for treating cancer; Pectin for pharmaceutical purposes; Colloid injections in the nature of sodium alginate and ion solutions for medical purposes, not including radioactive substances, thyroid hormone preparations, or para-thyroid hormone preparations; Pharmaceutical preparations for the detection, diagnosis, monitoring and treatment of cancer
t-acegel

General Information

Serial Number90819587
Word MarkT-ACEGEL
Filing DateFriday, July 9, 2021
Status700 - REGISTERED
Status DateTuesday, February 13, 2024
Registration Number7306959
Registration DateTuesday, February 13, 2024
Mark Drawing5 - Drawing with word(s) / letter(s) / number(s) in Stylized form
Published for Opposition DateNOT AVAILABLE

Trademark Statements

Description of MarkThe mark consists of the term "T-ACEGEL" in stylized format.
Certificate of Correction for RegistrationIn the statement, line 11 - 12, "EXPIRES 03-16-2031" should be deleted, and "EXPIRES 03-15-2031" should be inserted.
Goods and ServicesDiagnostic reagents and contrast media for medical use; Medicines for human purposes, namely, medicines for treating cancer; Pectin for pharmaceutical purposes; Colloid injections in the nature of sodium alginate and ion solutions for medical purposes, not including radioactive substances, thyroid hormone preparations, or para-thyroid hormone preparations; Pharmaceutical preparations for the detection, diagnosis, monitoring and treatment of cancer
Pseudo MarkT-ACE GEL

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateThursday, September 16, 2021
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameT-ACE Medical Co., Ltd.
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressTainan City 74147
TW
Party NameT-ACE Medical Co., Ltd.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressTainan City 74147
TW

Trademark Events

Event DateEvent Description
Tuesday, July 13, 2021NEW APPLICATION ENTERED
Thursday, September 16, 2021NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Tuesday, March 29, 2022ASSIGNED TO EXAMINER
Tuesday, April 12, 2022NON-FINAL ACTION WRITTEN
Tuesday, April 12, 2022NON-FINAL ACTION E-MAILED
Tuesday, April 12, 2022NOTIFICATION OF NON-FINAL ACTION E-MAILED
Tuesday, October 11, 2022TEAS RESPONSE TO OFFICE ACTION RECEIVED
Tuesday, October 11, 2022CORRESPONDENCE RECEIVED IN LAW OFFICE
Wednesday, October 12, 2022TEAS/EMAIL CORRESPONDENCE ENTERED
Monday, November 21, 2022FINAL REFUSAL WRITTEN
Monday, November 21, 2022FINAL REFUSAL E-MAILED
Monday, November 21, 2022NOTIFICATION OF FINAL REFUSAL EMAILED
Tuesday, January 3, 2023NON-FINAL ACTION WRITTEN
Tuesday, January 3, 2023NON-FINAL ACTION E-MAILED
Tuesday, January 3, 2023NOTIFICATION OF NON-FINAL ACTION E-MAILED
Thursday, March 23, 2023EXAMINERS AMENDMENT -WRITTEN
Thursday, March 23, 2023EXAMINERS AMENDMENT E-MAILED
Thursday, March 23, 2023NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Thursday, March 23, 2023EXAMINER'S AMENDMENT ENTERED
Monday, March 27, 2023APPROVED FOR REGISTRATION SUPPLEMENTAL REGISTER
Monday, April 10, 2023ASSIGNED TO LIE
Friday, April 14, 2023LAW OFFICE PUBLICATION REVIEW COMPLETED
Tuesday, May 2, 2023WITHDRAWN FROM PUB - OG REVIEW QUERY
Tuesday, May 16, 2023PREVIOUS ALLOWANCE COUNT WITHDRAWN
Friday, May 19, 2023NON-FINAL ACTION WRITTEN
Friday, May 19, 2023NON-FINAL ACTION E-MAILED
Friday, May 19, 2023NOTIFICATION OF NON-FINAL ACTION E-MAILED
Monday, August 21, 2023EXAMINERS AMENDMENT -WRITTEN
Monday, August 21, 2023EXAMINERS AMENDMENT E-MAILED
Monday, August 21, 2023NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Monday, August 21, 2023EXAMINER'S AMENDMENT ENTERED
Wednesday, August 23, 2023APPROVED FOR REGISTRATION SUPPLEMENTAL REGISTER
Tuesday, February 13, 2024REGISTERED-SUPPLEMENTAL REGISTER
Friday, April 18, 2025TEAS RESPONSE TO OFFICE ACTION-POST REG RECEIVED
Tuesday, April 29, 2025CORRECTION UNDER SECTION 7 - PROCESSED
Friday, May 2, 2025ON HOLD - ELECTRONIC RECORD REVIEW REQUIRED
Tuesday, May 27, 2025NOTICE OF UPDATED REGISTRATION CONFIRMATION EMAILED
Tuesday, February 13, 2024NOTICE OF REGISTRATION CONFIRMATION EMAILED
Monday, June 24, 2024TEAS SECTION 7 REQUEST RECEIVED
Monday, December 30, 2024CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Wednesday, January 15, 2025POST REGISTRATION ACTION MAILED - SEC. 7

Related Keywords

acegel purposes preparations cancer pharmaceutical thyroid medicines hormone medical including substances